Literature DB >> 17443211

Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes.

P A Sarafidis1, A N Lasaridis, P M Nilsson, M I Pikilidou, P C Stafilas, A Kanaki, K Kazakos, J Yovos, G L Bakris.   

Abstract

The aim of this study was to evaluate the validity and reliability of homeostasis model assessment-insulin resistance (HOMA-IR) index, its reciprocal (1/HOMA-IR), quantitative insulin sensitivity check index (QUICKI) and McAuley's index in hypertensive diabetic patients. In 78 patients with hypertension and type II diabetes glucose, insulin and triglyceride levels were determined after a 12-h fast to calculate these indices, and insulin sensitivity (IS) was measured with the hyperinsulinemic euglycemic clamp technique. Two weeks later, subjects had again their glucose, insulin and triglycerides measured. Simple and multiple linear regression analysis were applied to assess the validity of these indices compared to clamp IS and coefficients of variation between the two visits were estimated to assess their reproducibility. HOMA-IR index was strongly and inversely correlated with the basic IS clamp index, the M-value (r=-0.572, P<0.001), M-value normalized with subjects' body weight or fat-free mass and every other clamp-derived index. 1/HOMA-IR and QUICKI indices were positively correlated with the M-value (r=0.342, P<0.05 and r=0.456, P<0.01, respectively) and the rest clamp indices. McAuley's index generally presented less strong correlations (r=0.317, P<0.05 with M-value). In multivariate analysis, HOMA-IR was the best fit of clamp-derived IS. Coefficients of variation between the two visits were 23.5% for HOMA-IR, 19.2% for 1/HOMA-IR, 7.8% for QUICKI and 15.1% for McAuley's index. In conclusion, HOMA-IR, 1/HOMA-IR and QUICKI are valid estimates of clamp-derived IS in patients with hypertension and type II diabetes, whereas the validity of McAuley's index needs further evaluation. QUICKI displayed better reproducibility than the other indices.

Entities:  

Mesh:

Year:  2007        PMID: 17443211     DOI: 10.1038/sj.jhh.1002201

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  60 in total

1.  [13C]glucose breath testing provides a noninvasive measure of insulin resistance: calibration analyses against clamp studies.

Authors:  Maysa Hussain; Morteza Jangorbhani; Sally Schuette; Robert V Considine; Robin L Chisholm; Kieren J Mather
Journal:  Diabetes Technol Ther       Date:  2013-10-11       Impact factor: 6.118

Review 2.  Risk factors preceding type 2 diabetes and cardiomyopathy.

Authors:  Shamjeet Singh; Sanjiv Dhingra; Dan D Ramdath; Sudesh Vasdev; Vicki Gill; Pawan K Singal
Journal:  J Cardiovasc Transl Res       Date:  2010-07-01       Impact factor: 4.132

3.  Oxidative stress in adult growth hormone deficiency: different plasma antioxidant patterns in comparison with metabolic syndrome.

Authors:  Antonio Mancini; Chantal Di Segni; Carmine Bruno; Giulio Olivieri; Francesco Guidi; Andrea Silvestrini; Elisabetta Meucci; Patrick Orlando; Sonia Silvestri; Luca Tiano; Alfredo Pontecorvi
Journal:  Endocrine       Date:  2017-11-15       Impact factor: 3.633

4.  Comparison between surrogate indexes of insulin sensitivity/resistance and hyperinsulinemic euglycemic glucose clamps in rhesus monkeys.

Authors:  Ho-Won Lee; Ranganath Muniyappa; Xu Yan; Lilly Q Yue; Ellen H Linden; Hui Chen; Barbara C Hansen; Michael J Quon
Journal:  Endocrinology       Date:  2011-01-05       Impact factor: 4.736

5.  β-cell dysfunction in adolescents and adults with newly diagnosed type 2 diabetes mellitus.

Authors:  Deborah A Elder; Patricia M Herbers; Tammy Weis; Debra Standiford; Jessica G Woo; David A D'Alessio
Journal:  J Pediatr       Date:  2012-01-10       Impact factor: 4.406

6.  A comparison of novel and commonly-used indices of insulin sensitivity in African American chronic hemodialysis patients.

Authors:  Adriana M Hung; Mary B Sundell; Phyllis Egbert; Edward D Siew; Ayumi Shintani; Charles D Ellis; Aihua Bian; T Alp Ikizler
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-24       Impact factor: 8.237

7.  Safety of aerobic exercise in people with diabetic peripheral neuropathy: single-group clinical trial.

Authors:  Patricia M Kluding; Mamatha Pasnoor; Rupali Singh; Linda J D'Silva; Min Yoo; Sandra A Billinger; Joseph W LeMaster; Mazen M Dimachkie; Laura Herbelin; Douglas E Wright
Journal:  Phys Ther       Date:  2014-10-02

8.  Liver fat percent is associated with metabolic risk factors and the metabolic syndrome in a high-risk vascular cohort.

Authors:  Michel R Hoenig; Gary Cowin; Raymond Buckley; Christine McHenery; Alan Coulthard
Journal:  Nutr Metab (Lond)       Date:  2010-06-16       Impact factor: 4.169

9.  MRI sagittal abdominal diameter is a stronger predictor of metabolic syndrome than visceral fat area or waist circumference in a high-risk vascular cohort.

Authors:  Michel R Hoenig
Journal:  Vasc Health Risk Manag       Date:  2010-08-09

10.  Eight-month follow-up of physical activity and central adiposity: results from an Internet-delivered randomized control trial intervention.

Authors:  Lucas J Carr; R Todd Bartee; Chris M Dorozynski; James F Broomfield; Marci L Smith; Derek T Smith
Journal:  J Phys Act Health       Date:  2009-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.